AFC-HD AMS Life Science Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
AFC-HD AMS Life Science Co., Ltd. carries a market capitalization of 12.54B, placing it among publicly traded companies globally.
| Market Cap | 12.54B |
| Enterprise Value | N/A |
Financial Position
The debt-to-equity ratio is 649.96, indicating elevated leverage, while an interest coverage ratio of 17.17 demonstrates strong ability to service its debt obligations.
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 649.96 |
| Debt / EBITDA | N/A |
| Interest Coverage | 17.17 |
Financial Efficiency
AFC-HD AMS Life Science Co., Ltd. posts a return on equity of 8.08 and a return on invested capital of 5.39.
| Return on Equity (ROE) | 8.08 |
| Return on Assets (ROA) | 4.27 |
| Return on Invested Capital (ROIC) | 5.39 |
| Return on Capital Employed (ROCE) | 4.52 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.32 |
Taxes
Over the trailing twelve months, AFC-HD AMS Life Science Co., Ltd. has paid 507.60M in income taxes, reflecting an effective tax rate of 35.41.
| Income Tax | 507.60M |
| Effective Tax Rate | 35.41 |
Stock Price Statistics
AFC-HD AMS Life Science Co., Ltd.'s stock has gained approximately 0.23282887% over the past 52 weeks. The 50-day moving average sits at 843.80, while the 200-day moving average is 869.61.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.23282887% |
| 50-Day Moving Average | 843.80 |
| 200-Day Moving Average | 869.61 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached 1.44B, while operating income came in at 1.44B.
| Revenue | 23.40B |
| Gross Profit | 8.03B |
| Operating Income | 1.44B |
| Pretax Income | 1.43B |
| Net Income | 933.56M |
| EBITDA | 1.44B |
| EBIT | 1.44B |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Total book value stands at 12.29B, with working capital of -17.03B providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 9.87B |
| Equity (Book Value) | 12.29B |
| Book Value Per Share | N/A |
| Working Capital | -17.03B |
Margins
AFC-HD AMS Life Science Co., Ltd. operates with a gross margin of 34.30, reflecting its pricing power and cost economics. The operating margin of 6.14 and net profit margin of 3.99 provide insight into operational efficiency.
| Gross Margin | 34.30 |
| Operating Margin | 6.14 |
| Pretax Margin | 6.13 |
| Profit Margin | 3.99 |
| EBITDA Margin | 6.14 |
Stock Splits
AFC-HD AMS Life Science Co., Ltd.'s most recent stock split took place on August 29, 2011 with a 1:10 split ratio.
| Last Split Date | 8/29/2011 |
| Split Ratio | 1:10 |
Scores
AFC-HD AMS Life Science Co., Ltd. posts an Altman Z-Score of 4.76, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.76 |